Facebook (FB) PT Raised to $212 at Rosenblatt

Rosenblatt analyst Mark Zgutowicz raised the price target on Facebook (NASDAQ: FB) to $212.00 (from $206.00) while maintaining a Buy rating.

Zgutowicz commented, "In addition to a solid print and ‘no-surprises’ outlook, we were particularly pleased with relatively stable News Feed engagement, which importantly sets the table for Stories CPM inflection in CY20E. We also have more confidence in converging revenue and expense growth in CY20E and a subsequent “accelerating earnings growth” story."

You May Also Be Interested In

• Incyte (INCY) PT Raised to $105 at Truist Securities
• Forgent Power Solutions (FPS) PT Raised to $73 at TD Cowen
• Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities